Industry visionary is driving Veeva KOL Data to be the most
sophisticated information platform in life sciences
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva Systems (NYSE: VEEV) announced today that Kilian Weiss, general
manager of Veeva
KOL Data, was named to PharmaVOICE
magazine's prestigious annual list of the 100 most inspiring
people in the life sciences industry.
As one of the foremost global experts on stakeholder data, Kilian has
devoted the last decade to turning complex data and analytics into value
for life sciences companies. Originally conceived while conducting
research on social networks at the University of Frankfurt, his vision
was to help the industry connect the dots between their fragmented
customer data and analytics. Over the last decade he brought together
primary research, crowdsourcing, and healthcare transactional data to
construct and understand customer networks around the world. His
pioneering work has transformed the life sciences industry by enabling
an integrated model for stakeholder engagement.
“Kilian is a rare talent who has created groundbreaking new ways to
capture and analyze a complex sea of stakeholder data across the
healthcare landscape,” said Matt Wallach, president and co-founder of
Veeva. “His contributions to the industry will have lasting impact on
how life sciences companies use data to get drugs and treatments to the
right patients.”
Under Weiss’ leadership, Veeva launched KOL Data in 2015 and in one
year, five of the top 20 life sciences companies have become Veeva
customers. The subscription-based solution provides comprehensive
insights into global KOL data by combining the most extensive set of
data sources for complete coverage of stakeholders important to life
sciences companies, including thought leaders, payers, and regulators.
As a result, field teams can reduce the time they spend on meeting
preparation from hours down to seconds, and increase efficiency and
drive greater value throughout the enterprise.
“We’re seeing a massive industry shift from ad hoc KOL data gathering to
sophisticated, always up-to-date intelligence that is helping life
sciences organizations build lasting relationships,” said Kilian Weiss.
“I’m honored to be recognized by PharmaVOICE and will continue to
make it my mission to deliver the most complete single source of
stakeholder data with new levels of quality and scale for the industry.”
The PharmaVOICE 100 recognizes the inspirational leaders
representing a wide range of industry sectors and functional areas that
are having an extraordinary impact on their colleagues, companies, and
the greater healthcare community. This elite group leads by passionate
inspiration, contributes positively with unique approaches, addresses
the big challenges facing the industry, and presents innovative
strategies, products, and services.
Additional Information
To learn more about Veeva’s KOL Data services, visit: Veeva/KOLData
For
more on Veeva, visit: https://www.veeva.com/
Stay
updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 400 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended April 30, 2016. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160810005309/en/
Source: Veeva Systems Inc.